AI in Life Sciences – Regulating Risk, Liability and Innovation
The increasing importance of Artificial Intelligence, algorithms and Big Data in healthcare and life sciences has been a dominating feature in both law and policy discussions of late.
Clinical AI tools have shown promise in predicting health trajectories of patients, recommending treatments, guiding surgical care, monitoring patients, and supporting population health management (i.e., efforts to improve the health outcomes of a community). Other types of AI, such as administrative AI tools have shown promise in reducing provider burden and increasing efficiency by recording digital notes, optimizing operational processes.
These tools are at varying stages of maturity and adoption, but have already generated a considerable law and policy interest, leading to many novel regulatory proposals in EU, UK and US to name some jurisdictions. Issues such as liability, risk and biases have been in the forefront of the proposed regulations, while less attention has been focused on the impact of the proposed regulations for the innovation in this area. Gathering a panel of leading global experts on the matter of AI and Life Sciences the webinar has the ambition to explore various stakeholder perspectives related to challenges and promises of emerging AI technologies. Invited speakers:
Prof. Carmel Shachar, Executive Director of the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School.
Prof. Effy Vayena, Professor of Bioethics at the Swiss Institute of Technology (ETH) and renowned expert at the intersection of medicine, data, and ethics
Ms. Umuhany Zuhudi, General Manager of Digital Tech start-up Afya Rekod, a digital health platform that allows individuals to store their health information, engage with doctors, interact with verified health information.
Prof. Timo Minssen, Founder and Director, Center for Advanced Studies in Biomedical Innovation Law, Copenhagen University (moderator).
This is part of an ongoing webinar series in collaboration between International Federation of Pharma Manufacturers Associations (IFPMA) and University of Copenhagen, Faculty of Law, and administered by Center for Advanced Studies in Biomedical Innovation Law (CeBIL). See below for more information and previous webinars:
Click here to register.
You will receive a Zoom link shortly after registration.
For inquiries regarding registration or technical issues please contact Michelle Kjærulff email@example.com